Intranasal pirodavir (R77,975) treatment of rhinovirus colds
A randomized, double-blind, placebo-controlled trial assessed the therapeutic efficacy of intranasal pirodavir in naturally occurring rhinovirus colds. Adults with symptoms of < or = 2 days' duration were randomly assigned to intranasal sprays of pirodavir (2 mg per treatment) or placebo...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | 英语 |
| 出版: |
1995
|
| 在線閱讀: | https://doi.org/10.1128/aac.39.2.290 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|